The results of the EVOKE and EVOKE+ trials were comprehensive in showing oral semaglutide’s lack of clinical efficacy for ...

It was a beautiful day to host an event for a great cause, and that is just what the local Alzheimer’s Association was doing ...

After decades of slow progress in understanding and developing effective treatments for Alzheimer’s disease, scientists are ...

In the brain, Alzheimer’s is characterized by two proteins, amyloid beta and tau, that become dysfunctional, forming plaques ...

Some people with the gene did not have expected outcomes if they were heavy meat-eaters ...

Alzheimer's disease affects millions of people worldwide, yet the illness is hardest to catch at the very beginning, when new ...

Former KQRS Morning Show host Tom Barnard announced on his podcast that he has been undergoing treatment for Alzheimer's.

Research roundtable highlights early detection, biomarkers, interventions ...

A key Alzheimer’s drug has finally revealed its secret. Researchers discovered that lecanemab works by activating the brain’s immune cells—but only through a specific part of the antibody called the ...

New findings suggest that targeting inflammation in Alzheimer’s may matter as much as targeting protein buildup.

Science rarely hands us plot twists this dramatic—where two of the most feared diseases of our time, cancer and Alzheimer’s, ...

Genetic switches near the FTO locus may enable hibernators’ extreme metabolic resilience and could inspire future treatments ...